 Maryann Degroote
Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antitubercular Agents | 7 | 2014 | 208 | 0.700 |
Why?
| | Capreomycin | 1 | 2011 | 3 | 0.360 |
Why?
| | Mycobacterium | 3 | 2018 | 101 | 0.270 |
Why?
| | Models, Biological | 1 | 2011 | 1764 | 0.210 |
Why?
| | Tuberculosis | 3 | 2012 | 283 | 0.190 |
Why?
| | Mycobacterium tuberculosis | 5 | 2014 | 318 | 0.190 |
Why?
| | Tuberculosis, Pulmonary | 2 | 2014 | 127 | 0.180 |
Why?
| | Mycobacterium Infections | 3 | 2017 | 55 | 0.170 |
Why?
| | Benzothiazoles | 1 | 2018 | 39 | 0.140 |
Why?
| | Drug Discovery | 1 | 2018 | 153 | 0.130 |
Why?
| | Respiratory System | 1 | 2017 | 150 | 0.120 |
Why?
| | Anti-Bacterial Agents | 3 | 2018 | 1923 | 0.110 |
Why?
| | Isoniazid | 2 | 2012 | 70 | 0.110 |
Why?
| | Tuberculosis, Multidrug-Resistant | 2 | 2012 | 47 | 0.110 |
Why?
| | Phylogeny | 2 | 2017 | 917 | 0.100 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2012 | 196 | 0.100 |
Why?
| | Mice | 8 | 2018 | 18329 | 0.090 |
Why?
| | Monte Carlo Method | 1 | 2011 | 147 | 0.080 |
Why?
| | Torticollis | 1 | 2011 | 17 | 0.080 |
Why?
| | Tissue Distribution | 1 | 2011 | 335 | 0.080 |
Why?
| | Azithromycin | 1 | 2011 | 101 | 0.080 |
Why?
| | Biological Transport | 1 | 2011 | 424 | 0.080 |
Why?
| | Macrolides | 2 | 2011 | 67 | 0.080 |
Why?
| | Bayes Theorem | 1 | 2011 | 420 | 0.080 |
Why?
| | Autophagy | 1 | 2011 | 291 | 0.070 |
Why?
| | Cystic Fibrosis | 2 | 2011 | 1161 | 0.070 |
Why?
| | Otitis Media | 1 | 2011 | 182 | 0.070 |
Why?
| | Metabolomics | 1 | 2014 | 732 | 0.070 |
Why?
| | Computer Simulation | 1 | 2011 | 1003 | 0.060 |
Why?
| | Disease Models, Animal | 3 | 2012 | 4560 | 0.060 |
Why?
| | Bacterial Proteins | 1 | 2012 | 967 | 0.060 |
Why?
| | Molecular Epidemiology | 1 | 2005 | 73 | 0.060 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2005 | 77 | 0.050 |
Why?
| | Animals | 9 | 2018 | 38030 | 0.050 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2005 | 63 | 0.050 |
Why?
| | Kidney | 1 | 2011 | 1497 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2011 | 5983 | 0.050 |
Why?
| | Biomarkers | 1 | 2014 | 4295 | 0.050 |
Why?
| | Lung | 2 | 2012 | 4106 | 0.040 |
Why?
| | Drug Design | 2 | 2012 | 175 | 0.040 |
Why?
| | Mice, Inbred BALB C | 2 | 2012 | 1261 | 0.040 |
Why?
| | Amides | 1 | 2018 | 101 | 0.030 |
Why?
| | Mycolic Acids | 1 | 2017 | 6 | 0.030 |
Why?
| | Base Composition | 1 | 2017 | 82 | 0.030 |
Why?
| | Bacterial Typing Techniques | 1 | 2017 | 40 | 0.030 |
Why?
| | Oregon | 1 | 2017 | 76 | 0.030 |
Why?
| | Salmonella typhimurium | 1 | 1999 | 188 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 1999 | 308 | 0.030 |
Why?
| | Species Specificity | 1 | 2018 | 546 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2018 | 563 | 0.030 |
Why?
| | Genes, Bacterial | 1 | 2017 | 152 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2018 | 364 | 0.030 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 1999 | 337 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2017 | 320 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2017 | 507 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2005 | 2769 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 777 | 0.030 |
Why?
| | Female | 6 | 2014 | 78845 | 0.030 |
Why?
| | Humans | 9 | 2017 | 145475 | 0.030 |
Why?
| | Phagosomes | 1 | 2011 | 40 | 0.020 |
Why?
| | Pyrazinamide | 1 | 2011 | 16 | 0.020 |
Why?
| | Aza Compounds | 1 | 2011 | 12 | 0.020 |
Why?
| | COS Cells | 1 | 2011 | 177 | 0.020 |
Why?
| | Fluoroquinolones | 1 | 2011 | 44 | 0.020 |
Why?
| | Autopsy | 1 | 2011 | 94 | 0.020 |
Why?
| | Lysosomes | 1 | 2011 | 131 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2011 | 197 | 0.020 |
Why?
| | Ear, Middle | 1 | 2011 | 84 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2012 | 571 | 0.020 |
Why?
| | Rifampin | 1 | 2011 | 79 | 0.020 |
Why?
| | Microtubule-Associated Proteins | 1 | 2011 | 194 | 0.020 |
Why?
| | Drug Resistance, Bacterial | 1 | 2011 | 185 | 0.020 |
Why?
| | HIV Infections | 1 | 2005 | 3194 | 0.020 |
Why?
| | HeLa Cells | 1 | 2011 | 632 | 0.020 |
Why?
| | Sirolimus | 1 | 2011 | 280 | 0.020 |
Why?
| | Quinolines | 1 | 2011 | 190 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 666 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2011 | 1044 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2011 | 820 | 0.020 |
Why?
| | Guinea Pigs | 1 | 2008 | 159 | 0.020 |
Why?
| | Adult | 4 | 2014 | 40777 | 0.010 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2005 | 61 | 0.010 |
Why?
| | Treatment Outcome | 2 | 2014 | 11772 | 0.010 |
Why?
| | Age Distribution | 1 | 2005 | 403 | 0.010 |
Why?
| | Mycobacterium avium Complex | 1 | 2005 | 87 | 0.010 |
Why?
| | Sex Distribution | 1 | 2005 | 387 | 0.010 |
Why?
| | Reference Values | 1 | 2005 | 798 | 0.010 |
Why?
| | Macrophages | 1 | 2011 | 1507 | 0.010 |
Why?
| | Prospective Studies | 1 | 2014 | 8057 | 0.010 |
Why?
| | Genotype | 1 | 2005 | 1852 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2005 | 2121 | 0.010 |
Why?
| | Rats | 1 | 2008 | 5584 | 0.010 |
Why?
| | Incidence | 1 | 2005 | 2923 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1999 | 362 | 0.010 |
Why?
| | Isoenzymes | 1 | 1999 | 294 | 0.010 |
Why?
| | Virulence | 1 | 1999 | 278 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1999 | 267 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2005 | 3623 | 0.010 |
Why?
| | Disease Progression | 1 | 2005 | 2864 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2930 | 0.010 |
Why?
| | Male | 3 | 2014 | 72843 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2005 | 17291 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2005 | 5423 | 0.010 |
Why?
| | Risk Assessment | 1 | 2005 | 3747 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1999 | 2129 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1999 | 2883 | 0.010 |
Why?
| | Cohort Studies | 1 | 2005 | 6013 | 0.010 |
Why?
| | Middle Aged | 2 | 2005 | 36215 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2005 | 8333 | 0.010 |
Why?
| | Mutation | 1 | 1999 | 4075 | 0.000 |
Why?
| | Aged | 1 | 2005 | 26153 | 0.000 |
Why?
|
|
Degroote's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|